Org.nr 990 646 066 2016 → 2017 Year-over-year analysis

NYKODE THERAPEUTICS ASA: årsregnskap 2017 vs 2016

Grew 8% on revenue

approved 2018-04-10; registry 2018-06-23; journal 2018 530280

Summary

What changed

Comparing Årsregnskap 2017 with 2016 for NYKODE THERAPEUTICS ASA. Revenue 9.00m NOK → 9.76m NOK (+8.5%). Equity 234.40m NOK → 203.53m NOK.

On the constructive side: revenue rose; cash rose; owners injected capital. Pressures included: equity eroded.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for NYKODE THERAPEUTICS ASA.

At a glance

Revenue

9.00m NOK 9.76m NOK

+8.5%

Equity

234.40m NOK 203.53m NOK

-13.2%

Cash

19.63m NOK 40.28m NOK

+105.1%

Total assets

252.01m NOK 214.47m NOK

-14.9%

↑
Revenue rose

Operating income / revenue moved from 9.00m NOK to 9.76m NOK (+8.5% YoY). Calculated
↑
Cash rose

Bank deposits 19.63m NOK → 40.28m NOK (+105.1% YoY). Calculated
↑
Owners injected capital

Paid-in equity rose 289.36m NOK → 289.86m NOK (+497.6k NOK). Reported fact

↓
Equity eroded

Book equity 234.40m NOK → 203.53m NOK (equity ratio 93.0% → 94.9%). Calculated

·
Book investments changed

Investment / intangible book value 19.5k NOK → 45.9k NOK. Reported fact